| |
|
|
|
Clearpoint Neuro Inc  
|
|
23.42 1.78 (0.08%) |
02-26 16:00 |
|
Open: |
22.27 |
Pre close: |
21.64 |
Target:
|
30.55
|
|
High: |
23.57 |
Low: |
19.28 |
Resistance:
|
26.16
31.29
|
|
Volume: |
795,209 |
Market Cap: |
462M |
Support:
|
17.85
14.85
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
23.54
 |
MACD |
MACD(12,26):
|
0.97 |
|
MA(20): |
25.06 |
Signal(12,26,9): |
1.81 |
|
MA(100): |
13.99  |
Stochastic Oscillator |
%K(14,3):
|
37.85 |
|
MA(250): |
8.04 |
%D(3): |
38.85 |
|
Average Volume(K) |
3-Month: |
34287
|
52-Week |
High:
|
31.29 |
|
10-Days: |
74980 |
Low: |
2.86 |
|
RSI |
RSI(14):
|
50.49 |
Change(%): |
359.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-222.4 |
Shares Out. (M) |
17.07 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-19.1 |
Shares Float (M) |
12.71 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.71 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
20.2 |
% Held by Institutions |
6.17 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.432 |
Shares Short (K) |
275 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.302 |
P/E |
0.00 |
|
Sales Per Share |
0.722 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
-55.55 |
Operating Cash Flow
(M) |
-5.87 |
P/S |
32.45 |
|
Operating Margin |
-43.60 |
Levered Free Cash Flow
(M) |
-2.80 |
P/CF |
-68.11 |
|
|
|
|
|
|
